First Tracks Biotherapeutics, Inc. (TRAX)
50.53
-1.80
(-3.44%)
USD |
NASDAQ |
Nov 11, 16:00
50.20
-0.33
(-0.65%)
After-Hours: 20:00
First Tracks Biotherapeutics Price to Book Value : 12.01 for Nov. 11, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 11, 2026 | 12.01 |
| November 10, 2026 | 12.44 |
| November 09, 2026 | 11.82 |
| November 06, 2026 | 11.39 |
| November 05, 2026 | 10.80 |
| November 04, 2026 | 11.66 |
| November 03, 2026 | 11.02 |
| November 02, 2026 | 10.71 |
| October 30, 2026 | 10.72 |
| October 29, 2026 | 10.75 |
| October 28, 2026 | 10.87 |
| October 27, 2026 | 10.79 |
| October 26, 2026 | 10.34 |
| October 23, 2026 | 10.47 |
| October 22, 2026 | 10.26 |
| October 21, 2026 | 10.17 |
| October 20, 2026 | 9.807 |
| October 19, 2026 | 8.626 |
| October 16, 2026 | 8.193 |
| October 15, 2026 | 8.568 |
| October 14, 2026 | 8.114 |
| October 13, 2026 | 7.532 |
| October 12, 2026 | 8.095 |
| October 09, 2026 | 7.572 |
| October 08, 2026 | 7.610 |
| Date | Value |
|---|---|
| October 07, 2026 | 7.273 |
| October 06, 2026 | 7.463 |
| October 05, 2026 | 7.843 |
| October 02, 2026 | 7.912 |
| October 01, 2026 | 8.064 |
| September 30, 2026 | 8.426 |
| September 29, 2026 | 7.544 |
| September 28, 2026 | 7.683 |
| September 25, 2026 | 7.217 |
| September 24, 2026 | 7.512 |
| September 23, 2026 | 7.686 |
| September 22, 2026 | 8.603 |
| September 21, 2026 | 8.175 |
| September 18, 2026 | 8.093 |
| September 17, 2026 | 8.219 |
| September 16, 2026 | 8.177 |
| September 15, 2026 | 8.066 |
| September 14, 2026 | 7.877 |
| September 11, 2026 | 7.640 |
| September 10, 2026 | 7.963 |
| September 09, 2026 | 8.296 |
| September 08, 2026 | 8.764 |
| September 04, 2026 | 8.483 |
| September 03, 2026 | 8.913 |
| September 02, 2026 | 9.494 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AnaptysBio, Inc. | 136.97 |
| Mirum Pharmaceuticals, Inc. | -- |
| Biogen, Inc. | 1.979 |
| Immunovant, Inc. | 11.66 |
| ACADIA Pharmaceuticals, Inc. | 2.288 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1512 |
| Price | 50.53 |
| Earnings Yield | -8.83% |
| Market Cap | 1.814B |
| PEGY Ratio | -0.1512 |